Table 1 Characteristics of patients by initial visit
| Â | In-Person | Telemedicine | Â |
|---|---|---|---|
|  | N = 132 | N = 108 |  |
Sex | |||
 Female (%) | 67 (50.8) | 57 (52.8) |  |
 Male (%) | 65 (49.2) | 51 (47.2) |  |
|  |  |  | P = 0.796 |
Age | |||
 Median in  Years (IQR) | 69 (61, 75) | 66 (60, 75) |  |
|  |  |  | P = 0.678 |
Race | |||
 White (%) | 96 (72.7) | 79 (73.1) |  |
 Black (%) | 29 (22.0) | 19 (17.6) |  |
 Other/unknown (%) | 3 (2.3) | 7 (6.5) |  |
 Asian (%) | 4 (3.0) | 3 (2.8) |  |
|  |  |  | P = 0.387 |
Diagnosis | |||
 NSCLC (%) | 101 (76.5) | 75 (69.4) |  |
 SCLC (%) | 8 (6.1) | 12 (11.1) |  |
 Neuroendocrine (%) | 10 (7.6) | 6 (5.6) |  |
 Mesothelioma (%) | 5 (3.8) | 6 (5.6) |  |
 Thymoma (%) | 4 (3.0) | 2 (1.9) |  |
 Other (%) | 4 (3.0) | 7 (6.5) |  |
|  |  |  | P = 0.438 |
Therapy Received | |||
 Surgery (%) | 65 (49.2) | 13 (12.0) |  |
 Radiation (%) | 24 (18.2) | 34 (31.5) |  |
 Systemic therapy (%) | 29 (22.0) | 44 (40.7) |  |
 No therapy received (%) | 14 (10.6) | 17 (15.7) |  |
|  |  |  | P < 0.001 |
Phase of Care | |||
 New diagnosis (%) | 126 (95.5) | 84 (77.8) |  |
 Local recurrence (%) | 4 (3.0) | 8 (7.4) |  |
 Metastatic recurrence (%) | 2 (1.5) | 16 (14.8) |  |
|  |  |  | P < 0.001 |